tiprankstipranks
Life Science Reit Plc (GB:LABS)
LSE:LABS
UK Market

Life Science Reit Plc (LABS) Financial Statements

Compare
5 Followers

Life Science Reit Plc Financial Overview

Life Science Reit Plc's market cap is currently £119.35M. The company's EPS TTM is p-0.114; its P/E ratio is ―; and it has a dividend yield of 2.93%. Life Science Reit Plc is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21
Income Statement
Total Revenue£ 19.94M£ -19.92M£ 8.12M
Gross Profit£ 10.44M£ -28.48M£ 7.67M
Operating Income£ 28.08M£ -27.47M£ 7.74M
EBITDA£ 8.72M£ -65.04M£ 0.00
Net Income£ -21.71M£ -27.61M£ 7.74M
Balance Sheet
Cash & Short-Term Investments£ 14.34M£ 10.61M£ 165.96M
Total Assets£ 410.70M£ 447.82M£ 361.40M
Total Debt£ 107.92M£ 109.83M£ 0.00
Net Debt£ 93.58M£ 99.22M£ -165.96M
Total Liabilities£ 126.96M£ 128.37M£ 10.82M
Stockholders' Equity£ 283.75M£ 319.45M£ 350.58M
Cash Flow
Free Cash Flow£ -16.42M£ -8.73M£ 3.54M
Operating Cash Flow£ 7.62M£ -1.09M£ 3.54M
Investing Cash Flow£ -11.64M£ -186.38M£ -181.52M
Financing Cash Flow£ -27.24M£ 67.11M£ 343.94M
Currency in GBP

Life Science Reit Plc Earnings and Revenue History

Life Science Reit Plc Debt to Assets

Life Science Reit Plc Cash Flow

Life Science Reit Plc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis